EP0749319A4 - Cellules immortalisees et leurs utilisations - Google Patents

Cellules immortalisees et leurs utilisations

Info

Publication number: EP0749319A4
Authority: EP; European Patent Office
Prior art keywords: immortalized cells; immortalized; cells
Prior art date: 1992-09-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP19930920511

Other languages

German (de)

English (en)

Other versions

EP0749319A1 (fr

Inventor

Timothy J Miller

Stephen K Wikel

Rangappa N Ramachandra

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pfizer Corp Belgium

Pfizer Corp SRL

Oklahoma State University

Original Assignee

Pfizer Corp Belgium

Pfizer Corp SRL

Oklahoma State University

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-09-14

Filing date

1993-09-14

Publication date

1996-09-16

1993-09-14 Application filed by Pfizer Corp Belgium, Pfizer Corp SRL, Oklahoma State University filed Critical Pfizer Corp Belgium

1996-09-16 Publication of EP0749319A4 publication Critical patent/EP0749319A4/fr

1996-12-27 Publication of EP0749319A1 publication Critical patent/EP0749319A1/fr

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0233—Rickettsiales, e.g. Anaplasma
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Cell Biology (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Pharmacology & Pharmacy (AREA)
Urology & Nephrology (AREA)
Veterinary Medicine (AREA)
Microbiology (AREA)
Animal Behavior & Ethology (AREA)
Biomedical Technology (AREA)
Public Health (AREA)
Epidemiology (AREA)
Tropical Medicine & Parasitology (AREA)
Organic Chemistry (AREA)
Biochemistry (AREA)
Mycology (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Biotechnology (AREA)
Virology (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Insects & Arthropods (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

EP93920511A 1992-09-14 1993-09-14 Cellules immortalisees et leurs utilisations Withdrawn EP0749319A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US94487392A	1992-09-14	1992-09-14
PCT/US1993/008606 WO1994006463A1 (fr)	1992-09-14	1993-09-14	Cellules immortalisees et leurs utilisations
US944873		2001-08-31

Publications (2)

Publication Number	Publication Date
EP0749319A4 true EP0749319A4 (fr)	1996-09-16
EP0749319A1 EP0749319A1 (fr)	1996-12-27

Family

ID=25482205

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP93920511A Withdrawn EP0749319A1 (fr)	1992-09-14	1993-09-14	Cellules immortalisees et leurs utilisations

Country Status (5)

Country	Link
EP (1)	EP0749319A1 (fr)
JP (1)	JPH08502646A (fr)
AU (2)	AU5103293A (fr)
CA (1)	CA2144651A1 (fr)
WO (1)	WO1994006463A1 (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2264175B1 (fr)	1996-10-16	2012-11-21	ZymoGenetics, Inc.	Homologues de facteur de croissance fibroblastes
US6017757A (en) *	1997-02-20	2000-01-25	Mississippi State University	Isolated viable nematode intestinal cells
CN1344320A (zh)	1998-09-23	2002-04-10	津莫吉尼蒂克斯公司	细胞因子受体zalphall
ATE404668T1 (de)	1998-12-07	2008-08-15	Zymogenetics Inc	Wachstumsfaktor-homologe zvegf-3
CN1342202A (zh)	1999-01-07	2002-03-27	津莫吉尼蒂克斯公司	可溶性受体br43×2和应用方法
US7833529B1 (en)	1999-01-07	2010-11-16	Zymogenetics, Inc.	Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor
CN102406937A (zh)	1999-03-09	2012-04-11	津莫吉尼蒂克斯公司	新的细胞因子zalpha11配体
WO2001046422A1 (fr)	1999-12-23	2001-06-28	Zymogenetics, Inc.	La cytokine zcyto18
EP1325115B1 (fr)	2000-06-26	2016-07-27	ZymoGenetics, Inc.	Zcytor17, recepteur de la cytokine
DE60233888D1 (de)	2001-11-05	2009-11-12	Zymogenetics Inc	Il-21-antagonisten
ATE536406T1 (de)	2002-01-18	2011-12-15	Zymogenetics Inc	Neuartiger zytokin-zcytor17-ligand
DK1576112T3 (da)	2002-01-18	2012-06-25	Zymogenetics Inc	Cytokin-receptor zcytor17-multimerer
EP1497415B1 (fr)	2002-04-19	2010-12-29	ZymoGenetics, L.L.C.	Methodes d'identification ou modulation de l'interaction d'un recepteur de cytokine et son ligand
WO2005023862A2 (fr)	2003-08-07	2005-03-17	Zymogenetics, Inc.	Preparations homogenes d'il-28 et d'il-29
US7381794B2 (en)	2004-03-08	2008-06-03	Zymogenetics, Inc.	Dimeric fusion proteins and materials and methods for producing them
WO2006012644A2 (fr)	2004-07-29	2006-02-02	Zymogenetics, Inc.	Utilisation des molecules il-28 et il-29 pour traiter le cancer et les troubles autoimmuns
US8808696B2 (en)	2005-08-09	2014-08-19	Ares Trading S.A.	Methods for the treatment and prevention of abnormal cell proliferation using TACI-fusion molecules
CA2618765A1 (fr)	2005-08-09	2007-02-15	Zymogenetics, Inc.	Procedes destines au traitement des malignites des lymphocytes b au moyen d'une molecule de fusion taci-ig
AR060935A1 (es)	2006-05-15	2008-07-23	Ares Trading Sa	Metodos para tratar enfermedades autoinmunes utilizando una molecula de fusion taci- ig
US7754689B2 (en)	2006-06-02	2010-07-13	Wyeth Llc	Finger-1 peptide analogs of the TGF-β superfamily
EP2377876A1 (fr)	2006-06-02	2011-10-19	Wyeth LLC	Utilisation de protéines et de peptides de la superfamille TGF-BÊTA pour des procédés de purification et de thérapie
WO2008057396A2 (fr) *	2006-11-03	2008-05-15	Schering-Plough Ltd.	Vaccin contre la maladie de lyme canine
WO2008157263A2 (fr)	2007-06-15	2008-12-24	Arkansas State University	Procédés de distribution de molécule à des cellules en utilisant une sous-unité de ricine et compositions associées
WO2009120922A2 (fr)	2008-03-27	2009-10-01	Zymogenetics, Inc.	Compositions et procédés pour inhiber pdgfr-bêta et vegf-a
EP2313105B1 (fr)	2008-06-27	2013-07-24	ZymoGenetics, Inc.	RÉCEPTEURS Fc gamma HYBRIDES SOLUBLES ET PROCÉDÉS ASSOCIÉS
BR112012031329A2 (pt)	2010-06-09	2016-10-11	Zymogenetics Inc	proteínas de fusão diméricas vstm3 e composições e métodos relacionados
EP3597764A3 (fr)	2012-02-01	2020-05-06	SGI-DNA, Inc.	Matériau et procédés de synthèse de molécules d'acide nucléique à réduction d'erreurs
EP3328881B1 (fr)	2015-09-08	2019-08-28	Theripion, Inc.	Polypeptides de fusion apoa-1 ainsi que compositions et procédés associés
UA126278C2 (uk)	2015-09-21	2022-09-14	Аптево Рісьорч Енд Девелопмент Ллс	Поліпептиди, які зв'язують cd3
WO2018136163A2 (fr)	2016-12-09	2018-07-26	Theripion, Inc.	Polypeptides de fusion apoa-1 en tandem
US11725060B2 (en)	2017-07-20	2023-08-15	Aptevo Reserch and Development LLC	Antigen binding proteins binding to 5T4 and 4-1BB and related compositions and methods
IL275391B2 (en)	2017-12-20	2025-05-01	Harbour Biomed Shanghai Co Ltd	Antibodies binding ctla-4 and uses thereof
US10150801B1 (en)	2017-12-27	2018-12-11	Imunami Laboratories Pte. Ltd.	Recombinant polypeptides and methods of use thereof
CN111801346B (zh)	2017-12-27	2024-08-09	免疫实验室私人有限公司	重组多肽及其使用方法
US10675332B1 (en)	2019-08-26	2020-06-09	Imunami Laboratories Pte. Ltd.	Recombinant polypeptides and methods of use thereof
EP4021512A1 (fr)	2019-08-26	2022-07-06	Imunami Laboratories Pte. Ltd.	Polypeptides recombinants et leurs méthodes d'utilisation
CN116568317A (zh)	2020-06-22	2023-08-08	免疫实验室私人有限公司	用于癌症治疗的重组多肽和组合
US12180521B2 (en)	2021-02-19	2024-12-31	Theripion, Inc.	Paraoxonase fusion polypeptides and related compositions and methods
CN120584137A (zh)	2023-01-06	2025-09-02	阿帕特夫研究和发展有限公司	双特异性pd-l1和cd40结合分子以及其用途
WO2024259220A1 (fr)	2023-06-15	2024-12-19	Theripion, Inc.	Polypeptides de fusion de pon3 et de pon1 évoluée

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1988003929A1 (fr) *	1986-11-27	1988-06-02	Biotechnology Australia Pty. Ltd.	Vaccin contenant des antigenes de tiques

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4447537A (en) *	1981-01-22	1984-05-08	The United States Of Americas As Represented By The Department Of Health And Human Services	Tick cell lines
US5186933A (en) *	1986-12-30	1993-02-16	Baylor College Of Medicine	Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system

1993
- 1993-09-14 WO PCT/US1993/008606 patent/WO1994006463A1/fr not_active Ceased
- 1993-09-14 JP JP6508223A patent/JPH08502646A/ja active Pending
- 1993-09-14 AU AU51032/93A patent/AU5103293A/en not_active Abandoned
- 1993-09-14 EP EP93920511A patent/EP0749319A1/fr not_active Withdrawn
- 1993-09-14 CA CA002144651A patent/CA2144651A1/fr not_active Abandoned
1997
- 1997-12-11 AU AU48314/97A patent/AU4831497A/en not_active Abandoned

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1988003929A1 (fr) *	1986-11-27	1988-06-02	Biotechnology Australia Pty. Ltd.	Vaccin contenant des antigenes de tiques

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9406463A1 *

Also Published As

Publication number	Publication date
JPH08502646A (ja)	1996-03-26
EP0749319A1 (fr)	1996-12-27
AU5103293A (en)	1994-04-12
WO1994006463A1 (fr)	1994-03-31
AU4831497A (en)	1998-03-26
CA2144651A1 (fr)	1994-03-31

Publication	Publication Date	Title
EP0749319A4 (fr)	1996-09-16	Cellules immortalisees et leurs utilisations
EP0841950A4 (fr)	2000-01-19	Cellules souches neuronales et leurs utilisations
NO931864L (no)	1993-07-21	Inhibering av celle - adhesjon protein - karbohydrat - reaksjoner
KR950701068A (ko)	1995-02-20	하중 셀(Load cell)
EP1009415A4 (fr)	2000-10-25	INHIBITEURS DE $g(b)-LACTAMASES ET LEURS UTILISATIONS
DE69319983D1 (de)	1998-09-03	Zellkultureinsatz
NO981988L (no)	1998-06-30	Celleinneslutningsstruktur
DE69434300D1 (de)	2005-04-21	Solarzelle
FR2543743B1 (fr)	1987-04-24	Piles electrochimiques et leurs cathodes
DK162790D0 (da)	1990-07-06	Plantecelle
BR8901337A (pt)	1989-11-07	Conjunto de gaiola e rolete
ITMI931118A0 (it)	1993-05-31	Cellule dendritiche immortalizzate
MX165000B (es)	1992-10-13	Separador laminar y acumulador mejorado
DE69129404D1 (de)	1998-06-18	Speicherzelleschaltung und Matrix
FR2670215B1 (fr)	2000-10-13	Lignees de cellules immortalisees et leurs applications, notamment a la production de cellules differenciees.
FR2740680B1 (fr)	1997-12-12	Composition cosmetique solide et utilisations
NO955036L (no)	1995-12-12	Byggemoduler og konstruksjoner dannet av slike moduler
DK0462790T3 (da)	1997-06-16	Bygning og byggemetode
DE69229717D1 (de)	1999-09-09	Matrix von Graben-DRAM-Zellen
DE69120367D1 (de)	1996-07-25	Ladungsübertragungs- und/oder Verstärkungsanordnung
FI961848A0 (fi)	1996-04-30	Parannettu solunviljelymenetelmä ja -väliaine
FR2576020B1 (fr)	1989-12-08	5-halopyridine-3-carboxamides et leurs applications
FR2484425B1 (fr)	1986-05-16	Polyoxyalkylene-siloxanes speciaux et leurs applications
DE69314638D1 (de)	1997-11-20	Verbesserungen in oder in beziehung zu keksen
FI942600L (fi)	1994-06-02	Sähkökemiallinen kenno

Legal Events

Date	Code	Title	Description
1996-09-16	A4	Supplementary search report drawn up and despatched
1996-09-16	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE
1996-11-08	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1996-12-27	17P	Request for examination filed	Effective date: 19950711
1996-12-27	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE
1998-11-18	17Q	First examination report despatched	Effective date: 19981002
1999-06-25	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
1999-08-11	18D	Application deemed to be withdrawn	Effective date: 19990213